Skip to content
LinkedIn
Search
Search
The Business of Biofabrication
News
Perspectives
Learn
Landscape
Ricky Solorzano
July 13, 2026
STEMCELL Technologies and CCRM Build a Matched iPSC Path from Research to GMP
Ricky Solorzano
July 7, 2026
United Therapeutics Buys Thymmune: Why the Thymus May Become Critical Infrastructure for Organ Manufacturing
Ricky Solorzano
July 2, 2026
TREGZI and the Business of Precision-Built Cell Therapies
Ricky Solorzano
June 13, 2026
BellaSeno’s Mentor/J&J Collaboration Signals a New Chapter for Regenerative Soft-Tissue Implants
Ricky Solorzano
May 14, 2026
Why Hypoparathyroidism May Be the Best First Market for Biofabricated Endocrine Tissue Therapeutics
Ricky Solorzano
May 13, 2026
CTIBIOTECH Lands €1.25M from France 2030 to Industrialize 3D Bioprinted Tumors, and Take Aim at Oncology’s 95% Failure Problem
Ricky Solorzano
May 8, 2026
restor3d’s Aeros Ankle System Goes Full Commercial, 3D-Printed Orthopaedics Hits the Clinic
Ricky Solorzano
May 7, 2026
Miromatrix’s miroliverELAP Earns RMAT Designation
Ricky Solorzano
May 2, 2026
Hyalex Secures 510(k) Clearance for Cartilage-Mimicking Implant, Advancing Synthetic Biomaterials into Market
Ricky Solorzano
May 1, 2026
XellSmart Launches Phase II Trial of Off-the-Shelf iPSC Cell Therapy for Parkinson’s
Ricky Solorzano
Previous Page
1
2
3
4
…
16
Next Page
Archives
Subscribe
Subscribed
The Business of Biofabrication
Sign me up
Have a WordPress.com account?
Log in now.
The Business of Biofabrication
View site in Reader
Manage subscriptions
Sign up
Log in
Report this content
Collapse this bar
